Skip to main content

Table 1 Clinical characteristics of 244 Mycobacterium avium complex lung disease patients with and without chronic Pseudomonas aeruginosa infection

From: Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease

Characteristic

All patients

(n = 244)

With chronic infection

(n = 19)

Without chronic infection

(n = 225)

P value

Age, years

68 (62–75)

74 (67–76)

67 (61–75)

0.055

Sex, female

196 (80)

14 (74)

182 (81)

0.546

Disease duration, years

5.7 (2.3–9.7)

5.3 (2.3–10.3)

5.8 (2.3–9.6)

0.622

Body mass index, kg/m2

19.5 (17.5–21.3)

18.8 (17.3–21.2)

19.6 (17.5–21.3)

0.515

Smoking status

   

1.000

 Never

220 (90)

17 (89)

202 (90)

 

 Former

25 (10)

2 (11)

23 (10)

 

 Current

0 (0)

0 (0)

0 (0)

 

Charlson Comorbidity Index

0 (0–1)

1 (1–1)

0 (0–1)

0.048

Underlying pulmonary disease

    

 History of pulmonary TB

23 (9)

4 (21)

19 (8)

0.089

 Asthma

8 (3)

1 (1)

7 (3)

0.482

 COPD

2 (1)

0 (0)

2 (1)

1.000

 Lung cancer

3 (1)

1 (1)

2 (1)

1.000

 Interstitial lung disease

1 (0.4)

0 (0)

1 (0.4)

1.000

Treatment status

   

0.452

 Never

116 (48)

10 (53)

106 (47)

 

 Previous

40 (16)

1 (5)

39 (17)

 

 Current

88 (36)

8 (42)

80 (36)

 

Bacterial statusa

    

 Positive smear

83 (34)

3 (15)

80 (36)

0.083

 Positive culture

138 (57)

7 (37)

131 (59)

0.090

  1. Data show the median (interquartile range) or number (%) of patients
  2. TB, tuberculosis; COPD, chronic obstructive pulmonary disease
  3. aBacterial status for mycobacterium